About Nomocan pharmaceuticals

About company

NomoCan Pharmaceuticals offers targeted therapies for some of the most aggressive cancers with unmet medical needs. Its platform technology not only makes available a selective and specific diagnostic and prognostic test for early detection but more remarkably, it introduces highly effective monoclonal antibody (mAb) drugs for the treatment of various cancers in order to “Bring Hope” to patients affected by this devastating disease.​ The company is based in New York, New York.